Erratum to: Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: a prospective study (Heart Vessels (2011) 26, (523) DOI 10.1007/s00380-010-0086-0);Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: A prospective study

Heart and Vessels

Volumn 26, Issue 5, 2011, Pages 516-522

  Awidi, Abdalla ^a,b   Saleh, Akram ^a   Dweik, Manar ^b   Kailani, Baraah ^b   Abu Fara, Mohammed ^a   Nabulsi, Rinad ^a   Bener, Abdulbari ^c,d  

^a UNIVERSITY OF JORDAN   (Jordan)

^b JORDAN UNIVERSITY HOSPITAL   (Jordan)

^c HAMAD GENERAL HOSPITAL   (Qatar)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Aggregation; Aspirin; Cardiovascular diseases; Clopidogrel; Resistance

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD CLOTTING PARAMETERS; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPIRIN; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84855725350     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0171-z     Document Type: Erratum

References (38)

1. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Nagamachi K, Samukawa M (2010) Distribution of coronary atherosclerosis in patients with coronary artery disease. Heart Vessels 25:14-18
2. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y (2007) for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:69-171
3. Tseeng S, Arora R (2008) Aspirin resistance: biological and clinical implications. J Cardiovasc Pharmacol 13(1):5-12 (Pubitemid 351238288)
4. Matsuura K, Imamaki M, Ishida A, Shimura H, Miyazaki M (2009) The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. Heart Vessels 24:169-174
5. Harrison P, Segal H, Silver L, Anila S, Cuthbertson F, Peter M (2008) Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 19(2):119-124 (Pubitemid 351302375)
6. Steinhubl SR, Charnigo R, Moliterno DJ (2005) Resistance to antiplatelet resistance. J Am Coll Cardiol 45:1757-1758
7. Shantsila E, Lip GY (2008) 'Aspirin resistance' or treatment noncompliance: which is to blame for cardiovascular complications? J Transl Med 6:47-50
8. Mason P, Jacobs A, Freedman J (2005) Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol 46:986-993 (Pubitemid 41316504)
9. Michelson AD, Frelinger AL 3rd, Furman MI (2006) Current options in platelet function testing. Am J Cardiol 98(10):4-10
10. Mueller TH, Dieplinger B, Poelz W, Haltmayer M (2009) Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease. Clin Appl Thromb Hemost 15(6):652-659
11. Gurbel PA, Tantry US (2007) Clopidogrel resistance? Thromb Res 120(3):311-321 (Pubitemid 46881255)
12. Haubelt H, Anders C, Hellstern P (2005) Can platelet function tests predict the clinical efficacy of aspirin? Semin Thromb Hemost 31:404-410 (Pubitemid 41362345)
13. Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK (2005) Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 3(6):1309-1311 (Pubitemid 41725257)
14. Calatzis A, Wittwer M, Krueger B (2004) A new approach to platelet function analysis in whole blood-the Multiplate analyzer. Platelets 15:485-486
15. Mueller TH, Dieplinger B, Poelz W, Calatzis A, Meinhard H (2007) Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplateanalyzer - comparison with two flow cytometric methods. Thromb Res 121:249-258 (Pubitemid 350148206)
16. Toth O, Calatzis A, Penz S (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781-788 (Pubitemid 44883819)
17. Seyfert UT, Haubelt H, Vogt A (2007) Variables influencing Multiplate (TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 18:199-206 (Pubitemid 46744118)
18. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US (2007) Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 115(25):3156-3164 (Pubitemid 47012230)
19. Weber AA, Przytulski B, Schanz A, Hohlfeld T, Schror K (2002) Towards a definition of aspirin resistance: a typological approach. Platelets 13:37-40 (Pubitemid 34169586)
20. Tantry US, Bliden KP, Gurbel PA (2005) Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 46:1705-1709 (Pubitemid 41531626)
21. Mueller MR, Salat A, Stangl P (1997) Variable platelet response to low dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78(3):1003-1007 (Pubitemid 27417291)
22. Berrouschot J, Schwetlick B, von Twickel G, Fischer C, Uhlemann H, Siegemund T, Siegemund A, Roessler A (2006) Aspirin resistance in secondary stroke prevention. Acta Neurol Scand 113(1):31-35
23. Gengo F, Rainka M, Robson M, Gengo M, Forrest A, Hourihane M, Bates V (2008) Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke. J Clin Pharmacol 48:335-343
24. Buchanan MR, Brister SJ (1995) Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 11(3):221-227
25. Gum P, Kottke-Marchant K, Poggio ED (1995) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230-235
26. Grundmann K, Jaschonek K, Kleine B, Dichgans J, Topka H (2003) Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 250:63-66 (Pubitemid 36206686)
27. Andersen K, Hurlen M, Arnesen H, Seljeflot I (2002) Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 108:37-42 (Pubitemid 36197660)
28. Sane DC, McKee SA, Malinin AI, Serebruany V (2002) Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin. Am J Cardiol 90:893-895
29. Grotemeyer KH, Scharafinski HW, Husstedt IW (1993) Two year follow-up of aspirin responder and aspirin nonresponder: a pilot study including 180 post stroke patients. Thromb Res 71(5):397-403
30. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial risk for cardiovascular events. Circulation 105:1650-1655
31. Helgason CM, Tortorice KL, Winkler SR, Penney DW, Schuler JJ, McClelland TJ, Brace LD (1993) Aspirin response and failure in cerebral infarction. Stroke 24:345-350 (Pubitemid 23070037)
32. Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV (2007) Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 153:175-181 (Pubitemid 46096871)
33. Pamukcu B, Oflaz H, Nisanci Y (2005) The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J 149(4):675-680
34. Liu Z, Yang Y, Mao Y, Wang X, Wang J, Huo Y (2008) Profile and prevalence of aspirin resistance in patients with metabolic syndrome. J Geriatr Cardiol 5(1):7-10
35. Tarján J, Salamon A, Jáger R, Poór F, Barczi V, Dinnyés J, Hamvas J, Kinczel A, Pál A, Blaskó G (1999) The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis. Orv Hetil 140(42):2339-2343
36. Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, Defranco A (2005) Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 95:973-975 (Pubitemid 40487749)
37. Zimmermann N, Wenk A, Kim U (2003) Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108:542-547 (Pubitemid 36961167)
38. Cotter G, Shemesh E, Zehavi M (2004) Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 147:293-300 (Pubitemid 38176831)